S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

FBIO Fortress Biotech Inc

1.75

-0.05 (-2.78%)

May 03 2024 - Closed

Delayed by 15 minutes

Avenue Therapeutics shares slide after IV tramadol NDA update

To read the full story on Seeking Alpha, click here.

Fortress Biotech (NASDAQ:FBIO)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Fortress Biotech Charts.

Fortress Biotech (NASDAQ:FBIO)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Fortress Biotech Charts.

Fortress Biotech Inc News

Mustang Bio Announces Closing of $4 Million Public Offering
Thursday 2 May 2024 (2 days ago) • GlobeNewswire Inc.

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
Wednesday 1 May 2024 (3 days ago) • GlobeNewswire Inc.

Mustang Bio Announces Pricing of $4 Million Public Offering
Monday 29 April 2024 (4 days ago) • GlobeNewswire Inc.

Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
Monday 29 April 2024 (5 days ago) • GlobeNewswire Inc.

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
Thursday 25 April 2024 (1 week ago) • GlobeNewswire Inc.

Avenue Therapeutics Announces Reverse Stock Split
Wednesday 24 April 2024 (1 week ago) • GlobeNewswire Inc.

Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
Thursday 28 March 2024 (1 month ago) • GlobeNewswire Inc.

Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
Thursday 28 March 2024 (1 month ago) • GlobeNewswire Inc.

Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
Monday 25 March 2024 (1 month ago) • GlobeNewswire Inc.

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
Thursday 21 March 2024 (1 month ago) • GlobeNewswire Inc.

Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
Monday 18 March 2024 (2 months ago) • GlobeNewswire Inc.

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
Monday 18 March 2024 (2 months ago) • GlobeNewswire Inc.

More Fortress Biotech Inc News Articles

Alternet Systems (PK)

Marketing Worldwide (PK)

Bell Buckle (PK)

Umbra Applied Technologies (PK)

Yuenglings Ice Cream (PK)

Moon Equity (PK)

Auto Parts 4Less (PK)

Ubiquitech Software (PK)

AMC Entertainment

Astra Energy (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions